| Silas Wong, MD | |
|
1240 Huffman Mill Rd, Burlington, NC 27215-8700 | |
| (336) 538-7411 | |
| Not Available |
| Full Name | Silas Wong |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1240 Huffman Mill Rd, Burlington, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841856010 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2023-00261 (North Carolina) | Primary |
| Entity Name | Wake Forest Emergency Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396216735 PECOS PAC ID: 7012819816 Enrollment ID: O20190312003619 |
News Archive
Concurrent failures of federal drinking water standards and Michigan's emergency manager law reinforced and magnified each other, leading to the Flint water crisis, according to a University of Michigan environmental policy expert.
Researchers at the Indiana University Melvin and Bren Simon Cancer Center have published the first report using imaging to show that changes in brain tissue can occur in breast cancer patients undergoing chemotherapy.
The research group of Dr. Fran-ois Robert, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), in collaboration with the team of Dr. Daniel Durocher (Samuel Lunenfeld Research Institute and University of Toronto) accomplished a technical breakthrough: they mapped all the fragile sites of a living organism, the budding yeast Saccharomyces cerevisiae. The method used by the researchers can be applied to humans. This study has been published online today in the scientific journal Nature Structural and Molecular Biology.
Pfizer has voluntarily recalled one lot (40,000 bottles) of 100 mg capsules of its epilepsy medication, Neurontin, after a manufacturing mechanical failure resulted in some bottles containing empty or partially filled capsules.
The Alzheimer's Drug Discovery Foundation announced today a $900,000 grant to AgeneBio, a pharmaceutical company developing innovative therapies for neurologic and psychiatric diseases. The grant will support the initiation of an FDA-registered Phase 3 clinical trial of AGB101, a new therapeutic treatment for amnestic mild cognitive impairment (aMCI).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Silas Wong, MD 1240 Huffman Mill Rd, Burlington, NC 27215-8700 Ph: (336) 538-7411 | Silas Wong, MD 1240 Huffman Mill Rd, Burlington, NC 27215-8700 Ph: (336) 538-7411 |
News Archive
Concurrent failures of federal drinking water standards and Michigan's emergency manager law reinforced and magnified each other, leading to the Flint water crisis, according to a University of Michigan environmental policy expert.
Researchers at the Indiana University Melvin and Bren Simon Cancer Center have published the first report using imaging to show that changes in brain tissue can occur in breast cancer patients undergoing chemotherapy.
The research group of Dr. Fran-ois Robert, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), in collaboration with the team of Dr. Daniel Durocher (Samuel Lunenfeld Research Institute and University of Toronto) accomplished a technical breakthrough: they mapped all the fragile sites of a living organism, the budding yeast Saccharomyces cerevisiae. The method used by the researchers can be applied to humans. This study has been published online today in the scientific journal Nature Structural and Molecular Biology.
Pfizer has voluntarily recalled one lot (40,000 bottles) of 100 mg capsules of its epilepsy medication, Neurontin, after a manufacturing mechanical failure resulted in some bottles containing empty or partially filled capsules.
The Alzheimer's Drug Discovery Foundation announced today a $900,000 grant to AgeneBio, a pharmaceutical company developing innovative therapies for neurologic and psychiatric diseases. The grant will support the initiation of an FDA-registered Phase 3 clinical trial of AGB101, a new therapeutic treatment for amnestic mild cognitive impairment (aMCI).
› Verified 6 days ago
Mary Funke, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-7000 | |
Dr. Anne-caroline M Garnier Norman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-716-2255 | |
Dr. Randolph Nicholas Brown, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-716-2255 | |
Paul Malinda, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-7050 Fax: 336-538-7041 | |
Caitlin Jernigan Rodgers, PA-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-7000 | |
Dr. Linda M Taylor, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-716-2255 | |
James Donald Strickland, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2708 Sturbridge Court, Burlington, NC 27215 Phone: 336-585-0938 |